Fairvalue-Calculator Fairvalue-Calculator
EN DE

Qinghai Spring Medicinal Resources Technology Co (600381) Fair Value & Analysis

Healthcare · CN · Market cap 3.1B CNY

Price¥5.29
Fair Value¥0.9500
Upside-82.0%
Quality95/100
Evidence: Medium Range ¥0.8000 – ¥1.11

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Qinghai Spring Medicinal Resources Technology Co (600381) currently trades at ¥5.29, while our model-based Fair Value estimate is ¥0.9500 — implying the stock looks roughly 82.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Qinghai Spring Medicinal Resources Technology Co., Ltd. manufactures and sells alcoholic beverages and health products in China. It operates through two segments, Wine and Beverage Fast-Moving Consumer Goods and Big Health. The Wine and Beverage Fast-Moving Consumer Goods segment focuses on the sales of alcoholic beverages, including the Tinghua series wines. The Big Health segment engages in the research, development, production, and sales of cordyceps and summer grass products. The company also actively explores new industrial sectors to create new growth points and ensure sustainable development. It serves consumers through distributors and dealers, and its products comply with national quality standards and production specifications. The company was founded in 2003 and is based in Xining, China.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +3193% Jiangsu Hengrui Pharmaceuticals Co (600276) -37% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -1% Hansoh Pharmaceutical Group (3692) -37% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Qinghai Spring Medicinal Resources Technology Co (600381) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥0.9500 versus a price of ¥5.29 — about −82% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 600381?
Our 21-model fair value for Qinghai Spring Medicinal Resources Technology Co is ¥0.9500 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥5.29.
What is the quality score of 600381?
Qinghai Spring Medicinal Resources Technology Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.